Suppr超能文献

大量输血综合征的化疗分析

CHEMOTHERAPY ANALYSIS IN MASSIVE TRANSFUSION SYNDROME.

作者信息

Stanković Bratislav, Stojanović Goran

出版信息

Med Pregl. 2016 Jan-Feb;69(1-2):37-43. doi: 10.2298/mpns1602037s.

Abstract

INTRODUCTION

Massive transfusion is defined as blood transfusion in quantities equal to or greater than the estimated patients' blood volume over a relatively short period of time (3-4 hours). The study was aimed at analyzing the application of chemotherapy in treatment of patients with acute massive bleeding and evaluating the results of hemostasis and platelet counts screening tests in the patients receiving massive transfusions.

MATERIAL AND METHODS

Attempts were made to fully compensate hemostatic factors in 24 patients (14 male and 10 female, aged 23 to 76 years) with acute massive and uncontrolled surgical bleeding (polytrauma, abdominal aortic aneurysm, digestive tract bleeding as a result of a farina overdose, mortus fetus) over the five-year period, wherein a circulating patients' blood volume was compensated over a relatively short period of time. First the surgical bleeding was stopped. The objective of chemotherapy was the combined use of resuspended red blood cells, fresh frozen plasma, cryoprecipitates and the platelet concentrate in order to maintain the patients' normal circulating blood volume and blood pressure (systolic blood pressure ≥ 100 mmHg) with hemoglobin value higher than 100 g/l and the hematocrit above 0.30 l/l.

RESULTS

Transfusion treatment of 24 patients with acute bleeding consisted of an average of 16 to 18 units of resuspended red blood cells (ranging from 4,880 ml to 5,220 ml); fresh frozen plasma (980 ml to 1,220 ml); cryoprecipitates (an average of 10 to 15 units i.e. 500-750 ml) and concentrated platelets (approximately an average of 8 to 12 units i.e. 240 to 360 ml).

CONCLUSION

In our study we have confirmed the pathophysiological mechanism shown in the available medical literature that after transfusion of a large red blood cell concentrate volume, dilutional coagulopathy develops, caused by a sharp drop in platelet count and the significantly reduced activity of unstable coagulation factors in the patient's circulation.

摘要

引言

大量输血的定义是在相对较短的时间(3 - 4小时)内输入等于或大于患者估计血容量的血量。本研究旨在分析化疗在急性大出血患者治疗中的应用,并评估大量输血患者的止血效果和血小板计数筛查试验结果。

材料与方法

在五年期间,对24例急性大量且无法控制的手术出血患者(14例男性和10例女性,年龄23至76岁)(多发伤、腹主动脉瘤、因食用过量淀粉引起的消化道出血、死胎)进行了止血因子的充分补充,在相对较短的时间内补充了患者的循环血容量。首先止住手术出血。化疗的目的是联合使用悬浮红细胞、新鲜冰冻血浆、冷沉淀和血小板浓缩物,以维持患者正常的循环血容量和血压(收缩压≥100 mmHg),血红蛋白值高于100 g/l,血细胞比容高于0.30 l/l。

结果

24例急性出血患者的输血治疗平均包括16至18单位的悬浮红细胞(4880 ml至5220 ml);新鲜冰冻血浆(980 ml至1220 ml);冷沉淀(平均10至15单位,即500 - 750 ml)和浓缩血小板(约平均8至12单位,即240至360 ml)。

结论

在我们的研究中,我们证实了现有医学文献中显示的病理生理机制,即在输入大量红细胞浓缩液后,会发生稀释性凝血病,这是由患者循环中血小板计数急剧下降和不稳定凝血因子活性显著降低引起的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验